A Novel Therapeutic Strategy to Control Conventional T-Cells While Supporting Treg Reconstitution Post-Transplant: Long-Term GVHD-Free Survival by Combining OX40L Blockade With Rapamycin
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.12.004
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Elsevier BV